[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"muscle-disorder\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:muscle-disorder":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,46,70,101],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":28,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":5},"100578283","observational-prospective-pmcf-study-to-confirm-performance-and-safety-of-intelect-devices-in-real-world-100578283",false,"NCT06809283","Observational Prospective PMCF Study to Confirm Performance and Safety of Intelect® Devices in Real World","Observational Prospective Post Market Clinical Follow-up (PMCF) Study to Confirm the Performance and Safety of the Chattanooga Intelect® Devices in Real World Use","INTELECT","Inclusion Criteria:\n\n1. Patients with musculoskeletal and skeletal muscle deficit disorders assigned to be treated with any of the Intelect® devices according to the current clinical practice at the selected sites and based on the opinion of the Investigator.\n2. Patient male or female with age ≥18 years old.\n3. Patient able to provide written informed consent. For France only: To be affiliated to the social security system or to be beneficiary of such system\n\nExclusion Criteria:\n\n1. Patients participating in another clinical study or who have completed a clinical study less than 30 days prior to enrollment.\n2. Patients who for any reason e.g. significant co-morbidities or other reasons, are considered by the Investigator unsuitable for study participation.","ALL","18 Years",{"count":20,"type":21},144,"ESTIMATED","OBSERVATIONAL","DJO UK Ltd (ENOVIS) is conducting this study to confirm the performance and safety of the Chattanooga Intelect® devices in real world use. This study will record post market clinical data on the use of a number of MDR-CE marked devices that are part of the Chattanooga Intelect® device family to ensure the continued acceptability of the benefit-risk ratio, and to identify possible systematic misuse or off-label use of the devices (Intelect® Mobile 2 Combo, Intelect® Mobile 2 Ultrasound, Intelect® Mobile 2 Electrotherapy (Stim), Intelect® Transport 2 Combo and Intelect® Transport 2 Ultrasound).",[25,26,27],"Musculoskeletal Disorders","Skeletal Disorder","Muscle Disorder",[29,30,31,32,33],"TENS","NMES","Ultrasound","Pain","ROM","RECRUITING","2025-11-14",{"date":37,"type":38},"2025-11-17","ACTUAL",{"date":40,"type":38},"2025-03-10",{"date":42,"type":21},"2026-12",{"name":44,"class":45},"DJO UK Ltd","INDUSTRY",{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":4,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":52,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":54,"conditions":55,"keywords":57,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":69},"100145625","characterization-of-familial-myopathy-and-paget-disease-of-bone-100145625","NCT01166854","Characterization of Familial Myopathy and Paget Disease of Bone","Inclusion Criteria: Male or Female age 18 and older\n\n* diagnose of Muscle or bone disorders\n* with a combination of medical problems including muscle and bone disease and their family members.\n\nExclusion Criteria:\n\n* under 18 year of age\n* unrelated diagnosis",{"count":53,"type":21},25,"The researcher wants to explore the genetic causes of muscle disease. The researcher is particularly interested in muscle disorders that occur in combination with diseases of bone that appear to be passed on from generation to generation.\n\nDiffuse Optical Spectroscopy will measure the concentrations of blood, water, and lipids (fats, for example) in your tissues. This device essentially measures the color of tissues in order to determine tissue physiology (its physical and chemical processes).",[27,56],"Bone Disorder",[58],"muscle and bone disease","2025-06-13",{"date":61,"type":38},"2025-06-18",{"date":63,"type":38},"2010-06-18",{"date":65,"type":21},"2030-06",{"name":67,"class":68},"University of California, Irvine","OTHER",1,{"id":71,"slug":72,"hasResults":11,"nctId":73,"briefTitle":74,"officialTitle":74,"acronym":75,"eligibilityCriteria":76,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":77,"targetDuration":4,"studyType":79,"phases":80,"briefSummary":82,"conditions":83,"keywords":91,"overallStatus":92,"whyStopped":4,"lastUpdateSubmitDate":40,"lastUpdatePostDateStruct":93,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":69},"100583020","impact-of-sarcopenia-on-dyspnea-in-patients-with-asthma-100583020","NCT06870890","Impact of Sarcopenia on Dyspnea in Patients With Asthma","MUDYSA","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Patient affiliated to a social security scheme.\n* Patient capable of giving free, informed, written and signed consent.\n* Asthmatic patients with a diagnosis made by a pulmonologist on GINA level 4 or 5 treatment\n* ACT asthma control score \\\u003C 20\n* Patient judged by the investigator to be able to to perform a maximal exercise test.\n\nExclusion Criteria:\n\n* Patient under guardianship\u002Ftrusteeship\u002Fsupervision of justice\n* Pregnant or breast-feeding women\n* Unstable heart disease\n* Patients who have been smoking or have stopped smoking for less than 5 years,",{"count":78,"type":21},100,"INTERVENTIONAL",[81],"NA","Dyspnea in asthma, is mainly due to airway obstruction but can be caused by several alternative diagnoses.\n\nThe impact of sarcopenia on dyspnea in patients with asthma is unknown. Sarcopenic asthma had a reduced physical activity and is associated with airway obstruction compared to non-sarcopenic asthma. In patients with obstructive pulmonary disease, sarcopenia is associated with shallow breathing and diverse sensory and affective components of exertional dyspnea .\n\nThe morbidity of sarcopenia is also increased by systemic inflammation and the production of inflammatory cytokines as found in inflammatory airway obstruction.\n\nThe investigators will investigate the prevalence and impact of sarcopenia in asthmatics patients. This will enable to better manage sarcopenia in asthmatic patients, understand its origins and personalize treatment.",[84,85,86,87,88,89,90,27],"Sarcopenia","Asthma","Dyspnea","Dyspnea; Asthmatic","Cytokines","Adipokines","Myokine",[85,84,86],"NOT_YET_RECRUITING",{"date":94,"type":38},"2025-03-11",{"date":96,"type":21},"2025-03-25",{"date":98,"type":21},"2026-10",{"name":100,"class":68},"University Hospital, Clermont-Ferrand",{"id":102,"slug":103,"hasResults":11,"nctId":104,"briefTitle":105,"officialTitle":105,"acronym":4,"eligibilityCriteria":106,"healthyVolunteers":107,"sex":17,"minAge":108,"maxAge":109,"enrollmentInfo":110,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":112,"conditions":113,"keywords":117,"overallStatus":92,"whyStopped":4,"lastUpdateSubmitDate":120,"lastUpdatePostDateStruct":121,"startDateStruct":123,"completionDateStruct":125,"leadSponsor":127,"locationsCount":4},"100571504","investigation-of-grip-strength-pain-and-anxiety-levels-in-dentists-100571504","NCT06721117","Investigation of Grip Strength, Pain and Anxiety Levels in Dentists","Inclusion Criteria:\n\n* Graduating from the Faculty of Dentistry\n* Having 1 year or more professional experience\n\nExclusion criteria;\n\n* Having received physical therapy from any area in the last 6 months or currently receiving physical therapy,\n* Having a congenital musculoskeletal deformity,\n* Having a neurological or rheumatic disease,\n* Having undergone surgery due to a musculoskeletal disorder.",true,"20 Years","50 Years",{"count":111,"type":21},50,"The aim of the study is to evaluate the relationship between professional experience and grip strength, pain threshold and anxiety level in dentists. As a result of the results obtained, we aim to contribute an original study to the literature and to increase awareness by informing the dentists participating in the study.",[114,27,115,116],"Grip","Pain, Chronic","Anxiety",[118,119],"pain","pain thereshold","2024-12-05",{"date":122,"type":38},"2024-12-06",{"date":124,"type":21},"2024-12-01",{"date":126,"type":21},"2025-01-30",{"name":128,"class":68},"Hacettepe University"]